CVR 44514869Private limited company (ApS)Detailhandel med andre medicinske og ortopædiske artikler (477420)Secondary industries: Køb og salg af egen fast ejendom (681100)Frederiksberg CFounded 21 Dec 2023
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Medimi Danmark ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, 2025
Gross profit
-137.4K
DKK, annual report 2025
Result
-670.2K
DKK, annual report 2025
Equity
52.8K
DKK, annual report 2025
Medimi AB100% of capital and votes
Operating company
Dandex estimate: 1 employee registered in 2025; status is not activeLars Johan Wieseluntil 14 May 2025
Owners of 5% or more. CVR registers shares in bands, not exact figures.
100% of capital and votessince 21 Dec 2023
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Mar 2025, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Mar 2025, published 29 Jul 2025.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Gross profit -137.4K, Operating profit -655.7K, Result for the year -670.2K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 99.6K, Equity 52.8K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2024 | 2025 |
|---|---|---|
| Gross profit | -1,134 | -137 |
| Operating profit | -2,137 | -656 |
| Result for the year | -2,137 | -670 |
| Equity | -2,097 | 53 |
| Total assets | 1,066 | 100 |
| Employees (average) | 1 | 1 |
| Credit metrics (Dandex calculations) | ||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | |
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Medimi Danmark ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 40,000 | None | 40,000 | None | 40,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
4 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Likvidation vedtaget 14.05.2025
Likvidatorer:
Tiltrådte:
Thomas Torre Christiansen, 3400 Hillerød, den 14.05.2025.
Bestyrelse:
Fratrådte:
Gun-Britt Fransson, den 14.05.2025, Maria Kristina Dackemark Lawesson, den 14.05.2025, Sven Anders Lennart Haskel, (formand), den 14.05.2025, Ulf Börje Mikael Lindahl, den 14.05.2025.
Direktion:
Fratrådte:
Lars Johan Wiesel, den 14.05.2025.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Ny adresse: c/o MG Konsult & Revision ApS, Harsdorffsvej 7A, st. tv, 1874 Frederiksberg C
Ny kommune: Frederiksberg
Vedtægter ændret: 17.03.2025
Nyt navn: Medimi Danmark ApS
Binavne: Medimi ApS.
Stiftelsesdato: 21.12.2023.
Virkningsdato: 21.12.2023.
Seneste vedtægtsdato: 21.12.2023.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
Medimi AB, Scheelvägen 17, 223 63 LUND, Sverige, den 21.12.2023.
Bestyrelse:
Sven Anders Lennart Haskel, (formand), den 21.12.2023, Gun-Britt Fransson, den 21.12.2023, Maria Kristina Dackemark Lawesson, den 21.12.2023, Ulf Börje Mikael Lindahl, den 21.12.2023.
Direktion:
Lars Johan Wiesel, den 21.12.2023.
Selskabet tegnes af en direktør i forening med et medlem af bestyrelsen
Første regnskabsår:
21.12.2023 - 31.12.2024.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er udvikling, produktion og salg af produkter inden for det medicintekniske område samt aktiviteter i tilknytning hertil, der omfatter produktion og salg af forbrugerprodukter inden for medicinforsyning. Selskabet skal endvidere kunne eje og forvalte fast ejendom og løsøre samt al hermed beslægtet virksomhed.
P-number 1029942079Harsdorffsvej 7, 1874 Frederiksberg C